Intercontinental Exchange said on Tuesday it would invest up to $2 billion in Polymarket, marking the New York Stock Exchange ...
Canal+ has committed to “double down” on local African content made with big budgets like Shaka iLembe as its $2B acquisition of South African giant MultiChoice closes, with CEO Maxime Saada today ...
Olo has laid off an undisclosed number of workers, the company confirmed in an email to Restaurant Dive. “These strategic organizational changes will enable us to focus our resources on the key areas ...
The company maintained fiscal year 2026 guidance with revenue between "$1.9 billion and $2 billion." Adjusted EBITDA remains between "$300 million and $320 million," and non-GAAP adjusted EPS is ...
CorMedix acquires Melinta Therapeutics in $300M deal Acquisition includes milestone payment tied to FDA approval of Rezzayo Melinta’s portfolio generated $120M revenue in 2024, with growth expected ...
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease. Arrowhead Pharmaceuticals has notched another ...
Vertex Pharmaceuticals commits $45 million upfront to leverage Enlaza Therapeutics’ War-Lock platform to create drug conjugates and T cell engagers for autoimmune diseases and gentler conditioning for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min As Busey Bank absorbs CrossFirst ...
In a regulatory filing, Qualcomm (QCOM) stated, “On August 25, 2025, Neil Martin, Senior Vice President, Finance and Chief Accounting Officer of Qualcomm, accepted the role of Senior Vice President, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback